Business Context and Reporting Period
This Form 8-K is filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc., as indicated in the metadata) on February 22, 2007. The report serves to announce the financial results for the company's third fiscal quarter ended December 31, 2006. The full details of these results are contained in a press release furnished as Exhibit 99.1, which is referenced but not included in the provided text.
Key Financial Metrics
The provided filing text does not contain specific numerical data regarding revenue, profit, cash flow, margins, debt, or liquidity. It solely references the issuance of a press release containing these figures.
Material Changes
The filing text does not provide specific details on material changes versus the prior comparable period. Investors must refer to the attached press release (Exhibit 99.1) for comparative analysis.
Guidance, Outlook, and Risks
The text does not include management commentary, forward-looking guidance, specific risk factors, or contingencies. It functions strictly as a notification of the press release's existence.
Investor Verification Checklist
- Verify the correct registrant name is Oculus Innovative Sciences, Inc., not Sonoma Pharmaceuticals, Inc.
- Locate and review Exhibit 99.1 (the press release dated February 22, 2007) to obtain actual financial figures for the quarter ended December 31, 2006.
- Confirm the fiscal quarter reporting period is Q3 2006.